The possibility that inclusion of RF-positive patients in the current series may have diluted the observed effect of the IL12B and IL23R variants in PsA susceptibility should be considered, particularly because some of these patients may be found to have RA with coincidental psoriasis. This evidence concerns the gene IL23R and rheumatoid arthritis.